pentazocine has been researched along with Alloxan Diabetes in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (42.86) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Asato, M; Carlsson, A; Fransson, R; Hallberg, M; Kamei, J; Koizumi, T; Nakanishi, Y; Nyberg, F; Ohsawa, M; Sandström, A | 1 |
Ganapathy, V; Ha, Y; Saul, A; Smith, SB; Tawfik, A; Zorrilla, EP | 1 |
Dun, Y; Duplantier, J; Ganapathy, V; Martin, PM; Mysona, B; Roon, P; Smith, SB | 1 |
Iwamoto, Y; Kamei, J; Kasuya, Y; Misawa, M; Nagase, H | 2 |
Donald, A; Kassiou, M; Mardon, K | 1 |
Khosla, P; Nagpal, RK; Singh, J; Srivastava, RK; Tandon, M | 1 |
7 other study(ies) available for pentazocine and Alloxan Diabetes
Article | Year |
---|---|
The dipeptide Phe-Phe amide attenuates signs of hyperalgesia, allodynia and nociception in diabetic mice using a mechanism involving the sigma receptor system.
Topics: Animals; Blotting, Western; Diabetes Mellitus, Experimental; Dipeptides; Hyperalgesia; Male; MAP Kinase Signaling System; Mice; Mice, Inbred ICR; Nociception; Pentazocine; Phosphorylation; Receptors, sigma; Reverse Transcriptase Polymerase Chain Reaction | 2011 |
Diabetes accelerates retinal ganglion cell dysfunction in mice lacking sigma receptor 1.
Topics: Aging; Animals; Cell Death; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Female; Gene Deletion; In Situ Nick-End Labeling; Intraocular Pressure; Mice; Mice, Inbred C57BL; Mice, Knockout; Neuroprotective Agents; Oxidative Stress; Pentazocine; Primary Cell Culture; Receptors, sigma; Retinal Ganglion Cells; Sigma-1 Receptor; Tonometry, Ocular; Xanthine Oxidase | 2012 |
In vivo protection against retinal neurodegeneration by sigma receptor 1 ligand (+)-pentazocine.
Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Ligands; Mice; Mice, Inbred C57BL; Pentazocine; Receptors, sigma; Retinal Degeneration; Retinal Ganglion Cells; Reverse Transcriptase Polymerase Chain Reaction; Sigma-1 Receptor | 2008 |
Antitussive effect of (+/-) pentazocine in diabetic mice is mediated by delta-sites, but not by mu- or kappa-opioid receptors.
Topics: Animals; Antitussive Agents; Diabetes Mellitus, Experimental; Injections, Intraventricular; Mice; Mice, Inbred ICR; Pentazocine; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Streptozocin | 1994 |
Effects of diabetes on the antinociceptive effect of (+/-)pentazocine in mice.
Topics: Analgesics; Animals; Diabetes Mellitus, Experimental; Drug Synergism; Male; Mice; Mice, Inbred ICR; Naltrexone; Narcotic Antagonists; Nociceptors; Pentazocine; Receptors, Opioid, kappa; Receptors, Opioid, mu | 1994 |
Effects of streptozotocin-induced diabetes on neuronal sigma receptors in the rat brain.
Topics: Analgesics, Opioid; Animals; Blood Glucose; Brain; Diabetes Mellitus, Experimental; Glycosuria; Guanidines; Haloperidol; Kinetics; Male; Pentazocine; Rats; Rats, Wistar; Receptors, sigma | 1999 |
Differential modulation of nociceptive responses to mu and kappa opioid receptor directed drugs by blood glucose in experimentally induced diabetes rats.
Topics: Animals; Blood Glucose; Buprenorphine; Diabetes Mellitus, Experimental; Female; Hyperglycemia; Morphine; Pain Measurement; Pentazocine; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Receptors, Opioid, mu | 2000 |